Roche Pharma AG (Germany)

Recent papers from Roche Pharma AG (Germany)

1. Enhanced melanoma-specific cytotoxic T-cell expansion and the clinical outcomes with simlukafusp alfa and pembrolizumab following checkpoint inhibitor progressionJournal for ImmunoTherapy of Cancer · 2026
2. Performance of the 10X Genomics flex single-cell sequencing assay and its application to overcome challenges in clinical trial samplesBMC Genomics · 2026
3. A longitudinal analysis of real world symptom tracking and patient-reported outcomes in Brisa, a German Digital Health App for multiple sclerosisPLOS Digital Health · 2026
4. Switches in alternatively spliced isoforms impact protein and drug interactions in melanoma, ovarian cancer, and acute myeloid leukemiaBritish Journal of Cancer · 2026
5. Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trialNature Medicine · 2026
6. Protein Therapeutic Quality Control Using Multi-Attribute Method (MAM): Challenges and Current Practice in cGMP EnvironmentsPharmaceuticals · 2026
7. Response to: Comment on ‘Comparing specificity and seroconversion sensitivity among major blood screening assays for human immunodeficiency virus and viral hepatitis’Vox Sanguinis · 2026
8. An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of piperacillin in human serum and plasmaClinical Chemistry and Laboratory Medicine (CCLM) · 2026
9. Discovery of novel protein biomarkers for the detection of polyendocrine metabolic ovarian syndrome phenotype AScientific Reports · 2026
10. An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of gentamicin in human serumClinical Chemistry and Laboratory Medicine (CCLM) · 2026
11. Cognitive components derived from traditional neuropsychological tests and their associations with plasma p-tau217 and p-tau181 in mild cognitive impairment: a multisite analysisGeroScience · 2026
12. A liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of vancomycin in human serum and plasmaClinical Chemistry and Laboratory Medicine (CCLM) · 2026
13. An isotope dilution-liquid chromatography-tandem mass spectrometry-based candidate reference measurement procedure for the quantification of meropenem in human serum and plasmaClinical Chemistry and Laboratory Medicine (CCLM) · 2026
14. Baseline and placebo-related imaging, cerebrospinal fluid, plasma biomarker, and cognitive findings in unimpaired PSEN1 E280A mutation carriers and non-carriers in the Alzheimer’s Prevention Initiative Autosomal Dominant Alzheimer’s Disease Colombia TrialEBioMedicine · 2026
15. Eluent Green – replacing acetonitrile and TFA for fully biodegradable and PFAS-free solvent systems, a paradigm shift toward green LC-MS biopharma analyticsGreen Analytical Chemistry · 2026
16. Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trialNature Medicine · 2026
17. Venous-capillary blood agreement for routine chemistry analytes: effects of collection site and sample matrixClinical Chemistry and Laboratory Medicine (CCLM) · 2026
18. Performance comparison of the LIAISON Murex Anti-HEV IgG/IgM and the Elecsys Anti-HEV IgG/IgM assays for the detection of hepatitis E virus infectionJournal of Clinical Virology · 2026
19. Revisiting the Carbon Footprint of Single‐Use Technologies in Biomanufacturing: A Bottom‐Up Analysis Reveals a Paradigm ShiftBiotechnology and Bioengineering · 2026
20. Upregulated CircRNAs With Efficacy in Preclinical In Vivo Models Reveal New Targets for Therapeutic Intervention in GliomaCancer Genomics & Proteomics · 2026